State GA
Clinical Trials in Georgia
Recruiting clinical trials with at least one study location in Georgia. Data updated daily from ClinicalTrials.gov.
Top Conditions in Georgia
NCT04956744 Phase 1
Recruiting
A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001...
Condition
Multiple Sclerosis
Enrollment
30 pts
Location
United States
Sponsor
ImStem Biotechnology
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT05126277 Phase 3
Recruiting
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With ...
Condition
Lupus Nephritis
Enrollment
462 pts
Location
United States, Argentina, Brazil
Sponsor
Novartis Pharmaceuticals
NCT06486428 N/A
Recruiting
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Condition
Small-cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Addario Lung Cancer Medical In
NCT04762199 Phase 1
Recruiting
MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cel...
Condition
Advanced Lung Non-Small Cell Carcinoma
Enrollment
69 pts
Location
United States
Sponsor
Emory University
NCT07103057 N/A
Recruiting
VIZ ACCESS HCM - Multi-Site Registry
Condition
Hypertrophic Cardiomyopathy
Enrollment
500 pts
Location
United States
Sponsor
Viz.ai, Inc.
NCT04630392 N/A
Recruiting
Effects of Treadmill Training and Whole-body Vibration in Children With Cerebral...
Condition
Cerebral Palsy
Enrollment
20 pts
Location
United States
Sponsor
Georgia State University
NCT05050136 Phase 2
Recruiting
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixib...
Condition
Primary Biliary Cholangitis
Enrollment
260 pts
Location
United States, Argentina, Belgium
Sponsor
Mirum Pharmaceuticals, Inc.
NCT05429736 N/A
Recruiting
Activating Spinal Circuits to Improve Walking, Balance, Strength, and Reduce Spa...
Condition
Incomplete Spinal Cord Injury
Enrollment
28 pts
Location
United States
Sponsor
Shepherd Center, Atlanta GA
NCT07276399 Phase 3
Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared Wit...
Condition
Squamous Cell Carcinoma of Head and Neck
Enrollment
500 pts
Location
United States, Australia, Austria
Sponsor
Janssen Research & Development
NCT07258511 Phase 3
Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 ...
Condition
Multiple Myeloma
Enrollment
400 pts
Location
United States, Australia, Brazil
Sponsor
Janssen Research & Development
NCT05417971 N/A
Recruiting
Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation
Condition
Hematologic Malignancy
Enrollment
20 pts
Location
United States
Sponsor
Northside Hospital, Inc.
NCT07207811 Phase 3
Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine...
Condition
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Enrollment
1,280 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
NCT06008093 Phase 3
Recruiting
A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combinati...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
280 pts
Location
United States
Sponsor
AstraZeneca
NCT06841354 Phase 3
Recruiting
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Comb...
Condition
Triple Negative Breast Neoplasms
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06955169 Phase 2
Recruiting
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care ...
Condition
Intracranial Meningioma
Enrollment
153 pts
Location
United States
Sponsor
RTOG Foundation, Inc.
NCT06660394 Phase 3
Recruiting
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults ...
Condition
Dravet Syndrome
Enrollment
160 pts
Location
United States, Australia, Belgium
Sponsor
Longboard Pharmaceuticals
NCT06203600 Phase 2, Phase 3
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophage...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
224 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04752722 Phase 1, Phase 2
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incom...
Condition
Superficial Bladder Cancer
Enrollment
350 pts
Location
United States, Australia, Canada
Sponsor
enGene, Inc.
NCT07353931 Phase 3
Recruiting
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthri...
Condition
Osteoarthritis
Enrollment
900 pts
Location
United States, Argentina, Belgium
Sponsor
Eli Lilly and Company
NCT05862272 Phase 3
Recruiting
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugoli...
Condition
Uterine Fibroids
Enrollment
1,000 pts
Location
United States
Sponsor
Sumitomo Pharma Switzerland Gm
NCT06506942 N/A
Recruiting
The TRICURE EFS Study
Condition
Tricuspid Valve Regurgitation
Enrollment
15 pts
Location
United States
Sponsor
TRiCares
NCT06296186 N/A
Recruiting
Massed Prolonged Exposure for PTSD in Substance Use Treatment
Condition
Stress Disorders, Post-Traumatic
Enrollment
200 pts
Location
United States
Sponsor
Veterans Medical Research Foun
NCT06784466 N/A
Recruiting
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patie...
Condition
Atrial Fibrillation (AF)
Enrollment
360 pts
Location
United States, Belgium, Croatia
Sponsor
Arga Medtech SA
NCT04862221 Phase 2
Recruiting
TReatment for ImmUne Mediated PathopHysiology
Condition
Acute Liver Failure
Enrollment
163 pts
Location
United States
Sponsor
National Institute of Diabetes